Immunophotonics to Present at the 2024 ThinkEquity Conference
St. Louis, Missouri, October 28, 2024 – PRISM MediaWire – Immunophotonics, Inc. a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, […]